Page last updated: 2024-09-03

n-glycolylneuraminic acid and Hemorrhagic Fever, Ebola

n-glycolylneuraminic acid has been researched along with Hemorrhagic Fever, Ebola in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bach, JM; Conchon, S; Duchi, R; Duvaux, O; Evanno, G; Galli, C; Jacquot, F; Judor, JP; Lagutina, I; Lazzari, G; Le Berre, L; Lheriteau, E; Mai, HL; Martinet, B; Perota, A; Perreault, H; Raoul, H; Reynard, O; Salama, A; Soulillou, JP; Volchkov, V1

Other Studies

1 other study(ies) available for n-glycolylneuraminic acid and Hemorrhagic Fever, Ebola

ArticleYear
Anti-EBOV GP IgGs Lacking α1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs.
    PloS one, 2016, Volume: 11, Issue:6

    Topics: Animals; Antibodies, Anti-Idiotypic; Antibodies, Viral; Ebola Vaccines; Ebolavirus; Galactose; Guinea Pigs; Hemorrhagic Fever, Ebola; Immunoglobulin G; Male; Neuraminic Acids; Swine; Vaccination; Viral Envelope Proteins; Viral Load

2016